ASX:PAR Paradigm Biopharmaceuticals Ltd. Share Price

What changed lately

• Latest news release · Sep 30, 2026

  Continuation of Suspension from Quotation

• Latest deck · Nov 19, 2025

  Shareholder Meeting (November 2025)

  Shareholder meeting · 26 slides

Latest news

All Paradigm Biopharmaceuticals Ltd. news

Financings

• Convertible Notes

  Sep 24, 2026

  Cancelled: convertible

  Buyers: Obsidian Global GP, LLC (US$2 million Tranche 4 drawdown; 2,000,000 Convertible Notes to be cancelled and funds returned)

  Use of proceeds: Ongoing Phase 3 clinical trial activities, including clinical operations, data management and regulatory activities

  Cancelled Sep 24, 2026

Read by 6ix AI from the company's releases

Decks

• Shareholder Meeting (November 2025)

  Shareholder meeting · 26 slides · Nov 19, 2025

• Evans & Partners 4th Annual Small Cap Healthcare Conference 2025

  Conference · 19 slides · Sep 9, 2025

• Investor Presentation (July 2025)

  Investor deck · 22 slides · Jul 31, 2025

• Investor Presentation (December 2024)

  Investor deck · 34 slides · Dec 9, 2024

Paradigm Biopharmaceuticals Ltd. on 6ix

Sector

Health care

Industry

Biotechnology

News releases

28 in the last 12 months · 231 in all · newest Oct 15, 2026 · oldest 2016

Decks

30 decks · latest Nov 19, 2025

Where Paradigm Biopharmaceuticals Ltd. is listed

Log in to ask 6ix AI your own questions about Paradigm Biopharmaceuticals Ltd.